Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
Add more filters










Publication year range
1.
Case Rep Surg ; 2021: 6649914, 2021.
Article in English | MEDLINE | ID: mdl-33680529

ABSTRACT

Delayed gastric emptying (DGE) is a common (20-30%) postoperative complication following pancreatoduodenectomy (PD) (Parmar et al., 2013). Various causes and preemptive measures have been suggested to decrease the occurrence of DGE. We added a simple step in the procedure of 26 consecutive pancreatic head resections, which seems to alleviate DGE and has never been highlighted before.

2.
Ann R Coll Surg Engl ; 101(5): 333-341, 2019 May.
Article in English | MEDLINE | ID: mdl-30854865

ABSTRACT

INTRODUCTION: We examine the influence of variations in provision of cardiac surgery in the UK at hospital level on patient outcomes and also to assess whether there is an inequality of access and delivery of healthcare. Cardiothoracic surgery has pioneered the reporting of surgeon-specific outcomes, which other specialties have followed. We set out to identify factors other than the individual surgeon, which can affect outcomes and enable other surgical specialties to adopt a similar model. MATERIALS AND METHODS: A retrospective analysis of prospectively collected data of patient and hospital level factors between 2013 and 2016 from 16 cardiac surgical units in the UK were analysed through the Society for Cardiothoracic Surgery of Great Britain and Ireland and the Royal College of Surgeons Research Collaborative. Patient demographic data, risks factors, postoperative complications and in-hospital mortality, as well as hospital-level factors such as number of beds and operating theatres, were collected. Correlation between outcome measures was assessed using Pearson's correlation coefficient. Associations between hospital-level factors and outcomes were assessed using univariable and multivariable regression models. RESULTS: Of 50,871 patients (60.5% of UK caseload), 25% were older than 75 years and 29% were female. There was considerable variation between units in patient comorbidities, bed distribution and staffing. All hospitals had dedicated cardiothoracic intensive care beds and consultants. Median survival was 97.9% (range 96.3-98.6%). Postoperative complications included re-sternotomy for bleeding (median 4.8%; range 3.5-6.9%) and mediastinitis (0.4%; 0.1-1.0%), transient ischaemic attack/cerebrovascular accident (1.7%; range 0.3-3.0%), haemofiltration (3.7%; range 0.8-6.8%), intra-aortic balloon pump use (3.3%; range 0.4-7.4%), tracheostomy (1.6%; range 1.3-2.6%) and laparotomy (0.3%; range 0.2-0.6%). There was variation in outcomes between hospitals. Univariable analysis showed a small number of positive associations between hospital-level factors and outcomes but none remained significant in multivariable models. CONCLUSIONS: Variations among hospital level factors exists in both delivery of, and outcomes, following cardiac surgery in the UK. However, there was no clear association between these factors and patient outcomes. This negative finding could be explained by differences in outcome definition, differences in risk factors between centres that are not captured by standard risk stratification scores or individual surgeon/team performance.


Subject(s)
Cardiac Surgical Procedures , Health Services Accessibility/statistics & numerical data , Healthcare Disparities/statistics & numerical data , Hospitals/statistics & numerical data , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Female , Hospital Mortality , Humans , Infant , Infant, Newborn , Male , Middle Aged , Outcome Assessment, Health Care , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Retrospective Studies , United Kingdom , Young Adult
3.
J Neurosci Methods ; 185(1): 133-42, 2009 Dec 15.
Article in English | MEDLINE | ID: mdl-19747507

ABSTRACT

The time-varying microstructure of sleep EEG spindles may have clinical significance in dementia studies and can be quantified with a number of techniques. In this paper, real and simulated sleep spindles were regarded as AM/FM signals modeled by six parameters that define the instantaneous envelope (IE) and instantaneous frequency (IF) waveforms for a sleep spindle. These parameters were estimated using four different methods, namely the Hilbert transform (HT), complex demodulation (CD), matching pursuit (MP) and wavelet transform (WT). The average error in estimating these parameters was lowest for HT, higher but still less than 10% for CD and MP, and highest (greater than 10%) for WT. The signal distortion induced by the use of a given method was greatest in the case of HT and MP. These two techniques would necessitate the removal of about 0.4s from the spindle data, which is an important limitation for the case of spindles with duration less than 1s. Although the CD method may lead to a higher error than HT and MP, it requires a removal of only about 0.23s of data. An application of this sleep spindle parameterization via the CD method is proposed, in search of efficient EEG-based biomarkers in dementia. Preliminary results indicate that the proposed parameterization may be promising, since it can quantify specific differences in IE and IF characteristics between sleep spindles from dementia subjects and those from aged controls.


Subject(s)
Dementia/diagnosis , Dementia/physiopathology , Electroencephalography/methods , Sleep Wake Disorders/diagnosis , Sleep Wake Disorders/physiopathology , Sleep/physiology , Aged , Algorithms , Biomarkers/analysis , Cerebral Cortex/physiopathology , Dementia/complications , Evoked Potentials/physiology , Fourier Analysis , Humans , Predictive Value of Tests , Sensitivity and Specificity , Signal Processing, Computer-Assisted , Sleep Wake Disorders/etiology , Time Factors
4.
Cell Prolif ; 42(4): 434-47, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19486015

ABSTRACT

OBJECTIVES: This study aimed to investigate molecular and cellular changes induced in human bone marrow mesenchymal stem cells (hMSCs) after treatment with microtubule-interacting agents and to estimate damage to the bone marrow microenvironment caused by chemotherapy. MATERIALS AND METHODS: Using an in vitro hMSC culture system and biochemical and morphological approaches, we studied the effect of nocodazole and taxol(R) on microtubule and nuclear envelope organization, tubulin and p53 synthesis, cell cycle progression and proliferation and death of hMSCs isolated from healthy donors. RESULTS AND CONCLUSIONS: Both nocodazole and taxol reduced hMSC proliferation and induced changes in the microtubular network and nuclear envelope morphology and organization. However, they exhibited only a moderate effect on cell death and partial arrest of hMSCs at G(2) but not at M phase of the cell cycle. Both agents induced expression of p53, exclusively localized in abnormally shaped nuclei, while taxol, but not nocodazole, increased synthesis of beta-tubulin isoforms. Cell growth rates and microtubule and nuclear envelope organization gradually normalized after transfer, in drug-free medium. Our data indicate that microtubule-interacting drugs reversibly inhibit proliferation of hMSCs; additionally, their cytotoxic action and effect on microtubule and nuclear envelope organization are moderate and reversible. We conclude that alterations in human bone marrow cells of patients under taxol chemotherapy are transient and reversible.


Subject(s)
Bone Marrow Cells/cytology , Bone Marrow Cells/drug effects , Mesenchymal Stem Cells/drug effects , Nocodazole/pharmacology , Paclitaxel/pharmacology , Tubulin Modulators/pharmacology , Bone Marrow Cells/metabolism , Cell Cycle/drug effects , Cell Death/drug effects , Cell Nucleus/drug effects , Cell Nucleus/ultrastructure , Cell Proliferation/drug effects , Cells, Cultured , Gene Expression/drug effects , Humans , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/metabolism , Microtubules/drug effects , Microtubules/ultrastructure , Nuclear Envelope/drug effects , Nuclear Envelope/ultrastructure , Tubulin/metabolism , Tumor Suppressor Protein p53/analysis , Tumor Suppressor Protein p53/genetics
5.
Eur J Surg Oncol ; 32(6): 666-70, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16618534

ABSTRACT

Paclitaxel and docetaxel are currently the two clinically available taxanes. The combination of a taxane and a platinum compound has become the systemic chemotherapy of choice for primary ovarian cancer. Despite the high activity of these drugs in systemic chemotherapy, the majority of patients with advanced ovarian cancer will develop recurrent disease and ultimately decease of this disease. Therefore, more effective systemic chemotherapy regimens or alternative treatment modalities are warranted. Intraperitoneal chemotherapy is such an alternative treatment option. Pharmacokinetic studies on intraperitoneal administration of paclitaxel and docetaxel demonstrated very high locoregional drug concentrations and exposure. Their activity and response seem to be dose-dependent and hence higher efficacy with limited systemic toxicity is to be expected. Intraperitoneal chemotherapy may be combined intraoperatively with hyperthermia, which enhances tissue penetration and cytotoxic activity of many drugs. The data concerning thermal enhancement of taxanes are inconsistent, but at the high locoregional concentrations provided by intraperitoneal drug administration such a thermal enhancement seems to exist. Clinical studies have clearly demonstrated the feasibility and efficacy of intraperitoneal instillation chemotherapy with taxanes in patients with ovarian cancer. Preliminary results of a phase III study demonstrated improved outcome with the addition of intraperitoneal instillation chemotherapy to systemic chemotherapy after optimal primary cytoreductive surgery. Intraoperative hyperthermic intraperitoneal chemotherapy with docetaxel has been performed in a single study, in which promising results were observed. Further clinical investigations with an adequate follow-up period are needed to confirm the promising initial results and to determine the exact efficacy of intraperitoneal chemotherapy with these drugs.


Subject(s)
Antineoplastic Agents, Phytogenic/therapeutic use , Ovarian Neoplasms/drug therapy , Paclitaxel/therapeutic use , Peritoneal Neoplasms/drug therapy , Taxoids/therapeutic use , Antineoplastic Agents, Phytogenic/pharmacokinetics , Docetaxel , Female , Humans , Hyperthermia, Induced , Infusions, Parenteral , Ovarian Neoplasms/pathology , Paclitaxel/pharmacokinetics , Peritoneal Neoplasms/secondary , Prognosis , Taxoids/pharmacokinetics
6.
EMBO Rep ; 2(10): 920-5, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11571267

ABSTRACT

We have recently shown that heterochromatin protein 1 (HP1) interacts with the nuclear envelope in an acetylation-dependent manner. Using purified components and in vitro assays, we now demonstrate that HP1 forms a quaternary complex with the inner nuclear membrane protein LBR and a sub-set of core histones. This complex involves histone H3/H4 oligomers, which mediate binding of LBR to HP1 and cross-link these two proteins that do not interact directly with each other. Consistent with previous observations, HP1 and LBR binding to core histones is strongly inhibited when H3/H4 are modified by recombinant CREB-binding protein, revealing a new mechanism for anchoring domains of under-acetylated chromatin to the inner nuclear membrane.


Subject(s)
Histones/metabolism , Acetylation , Animals , Binding Sites , Blotting, Western , Cell Nucleus/metabolism , Dose-Response Relationship, Drug , Electrophoresis, Polyacrylamide Gel , Fishes , Glutathione Transferase/metabolism , Heterochromatin/metabolism , Intracellular Membranes/metabolism , Mice , Models, Biological , Plasmids/metabolism , Precipitin Tests , Protein Binding , Protein Structure, Tertiary , Recombinant Fusion Proteins/metabolism , Recombinant Proteins/metabolism , Turkeys
7.
J Biol Chem ; 276(16): 13007-14, 2001 Apr 20.
Article in English | MEDLINE | ID: mdl-11278332

ABSTRACT

We have previously shown that the mouse heterochromatin protein 1 homologue M31 interacts dynamically with the nuclear envelope. Using quantitative in vitro assays, we now demonstrate that this interaction is potently inhibited by soluble factors present in mitotic and interphase cytosol. As indicated by depletion and order-of-addition experiments, the inhibitory activity co-isolates with a 55-kDa protein, which binds avidly to the nuclear envelope and presumably blocks M31-binding sites. Purification of this protein and microsequencing of tryptic peptides identify it as alpha2/6:beta2-tubulin. Consistent with this observation, bona fide tubulin, isolated from rat brain and maintained in a nonpolymerized state, abolishes binding of M31 to the nuclear envelope and aborts M31-mediated nuclear envelope reassembly in an in vitro system. These observations provide a new example of "moonlighting," a process whereby multimeric proteins switch function when their aggregation state or localization is altered.


Subject(s)
Chromosomal Proteins, Non-Histone/metabolism , Heterochromatin/metabolism , Nuclear Envelope/physiology , Tubulin/metabolism , Amino Acid Sequence , Animals , Brain/metabolism , Chromobox Protein Homolog 5 , Chromosomal Proteins, Non-Histone/chemistry , Endometrial Neoplasms , Female , HeLa Cells , Humans , Kinetics , Mice , Molecular Sequence Data , Molecular Weight , Nuclear Envelope/ultrastructure , Peptide Fragments/chemistry , Protein Binding , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Tumor Cells, Cultured
8.
EMBO J ; 19(23): 6558-68, 2000 Dec 01.
Article in English | MEDLINE | ID: mdl-11101528

ABSTRACT

To study the dynamics of mammalian HP1 proteins we have microinjected recombinant forms of mHP1alpha, M31 and M32 into the cytoplasm of living cells. As could be expected from previous studies, the three fusion proteins were efficiently transported into the nucleus and targeted specific chromatin areas. However, before incorporation into these areas the exogenous proteins accumulated in a peripheral zone and associated closely with the nuclear envelope. This transient association did not occur when the cells were treated with deacetylase inhibitors, indicating an acetylation-inhibited interaction. In line with these observations, recombinant HP1 proteins exhibited saturable binding to purified nuclear envelopes and stained the nuclei of detergent-permeabilized cells in a rim-like fashion. Competition experiments with various M31 mutants allowed mapping of the nuclear envelope-binding site within an N-terminal region that includes the chromodomain. A His(6)-tagged peptide representing this region inhibited recruitment of LAP2beta and B-type lamins around the surfaces of condensed chromosomes, suggesting involvement of HP1 proteins in nuclear envelope reassembly.


Subject(s)
Chromosomal Proteins, Non-Histone/metabolism , DNA-Binding Proteins , Nuclear Envelope/metabolism , Acetylation , Animals , Binding Sites , Binding, Competitive , CHO Cells , Cell Line , Cell Nucleus/metabolism , Chromatin/metabolism , Chromobox Protein Homolog 5 , Chromosomal Proteins, Non-Histone/chemistry , Chromosomal Proteins, Non-Histone/genetics , Chromosomes/metabolism , Cricetinae , Cytoplasm/metabolism , Detergents/pharmacology , Dose-Response Relationship, Drug , Electrophoresis, Polyacrylamide Gel , Fluorescent Antibody Technique, Indirect , Glutathione Transferase/metabolism , HeLa Cells , Humans , Immunoblotting , Kinetics , Lamins , Membrane Proteins/metabolism , Mice , Microinjections , Mitosis , Mutation , Nuclear Proteins/metabolism , Octoxynol/pharmacology , Protein Binding , Protein Transport , Recombinant Fusion Proteins/physiology
9.
Cancer Res ; 59(18): 4625-33, 1999 Sep 15.
Article in English | MEDLINE | ID: mdl-10493517

ABSTRACT

Treatment of human carcinoma cells with Taxol induces focal unraveling of the nuclear lamina and extensive clustering or ectopic localization of the nuclear pore complexes. These striking aberrations develop when the cells are transferred to drug-free medium and are allowed to complete mitosis. As could be confirmed by terminal deoxynucleotidyl transferase-mediated nick end labeling assays, 4,6-diamidino-2-phenylindole staining, 5-bromo-2-deoxyuridine incorporation, and examination of the nuclear lamins by Western blotting, the malformation of the nuclear envelope is not a consequence of apoptosis or G1 arrest. In fact, Taxol-treated cells possessing a defective nuclear envelope remain alive and replication-competent for at least 24 h, undergoing programmed death 72 h after removal of the drug. While still in the nonapoptotic state, these cells lose the ability to import karyophilic proteins into the nucleus. Diminished nucleocytoplasmic transport through the nuclear pore complex can be readily demonstrated by in vitro assays involving digitonin-permeabilized cells or in vivo monitoring of nuclear factor-kappaB translocation upon stimulation with tumor necrosis factor-alpha. These observations reveal novel cellular targets of antimicrotubule drugs and may pave the way for improved schemes of anticancer treatment.


Subject(s)
Cell Nucleus/drug effects , NF-kappa B/metabolism , Nuclear Envelope/drug effects , Paclitaxel/toxicity , Apoptosis , Bromodeoxyuridine/pharmacokinetics , Cell Cycle/drug effects , Cell Division/drug effects , Cell Nucleus/metabolism , Cell Nucleus/ultrastructure , Cell Survival/drug effects , HeLa Cells , Humans , In Situ Nick-End Labeling , Lamins , Microscopy, Video , Mitotic Index/drug effects , Nuclear Envelope/ultrastructure , Nuclear Proteins/metabolism , Tumor Cells, Cultured , Tumor Necrosis Factor-alpha/drug effects
10.
J Cell Sci ; 112 Pt 18: 3049-59, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10462521

ABSTRACT

Using autoimmune antibodies from a patient with primary biliary cirrhosis we have identified a 68 kDa nuclear envelope protein, termed PBC68. This protein is co-precipitated with a 98 kDa and a 250 kDa polypeptide and is distinct from the nuclear lamins. Immunostaining of digitonin-permeabilized cells indicates that PBC68 is restricted to the inner (nucleoplasmic) face of the nuclear envelope, while indirect immunofluorescence and immunoelectron microscopy show that PBC68 is located on fibrillar structures emanating from the nuclear pore complex. The autoantigen is modified at early prophase and disassembles at prometaphase concurrently with the breakdown of the nuclear envelope. The disassembled material, instead of diffusing throughout the cytoplasm as other nucleoporins, is targeted to the mitotic spindle and remains stably bound to it until anaphase. At telophase PBC68 is released from the mitotic apparatus and reassembles late, after incorporation of LAP2B and B-type lamins, onto the reforming nuclear envelope. The partitioning of PBC68 in dividing cells supports the notion that subsets of nuclear envelope proteins are actively sorted during mitosis by transiently anchoring to spindle microtubules. Furthermore, the data suggest that specific constituents of pore complex are released in a stepwise fashion from their anchorage sites before becoming available for nuclear reassembly.


Subject(s)
Nuclear Envelope/metabolism , Nuclear Proteins/metabolism , Autoantigens/chemistry , Autoantigens/metabolism , Binding Sites , Fluorescent Antibody Technique, Indirect , Humans , Liver Cirrhosis, Biliary/immunology , Microscopy, Immunoelectron , Molecular Weight , Nuclear Envelope/immunology , Nuclear Envelope/ultrastructure , Nuclear Proteins/chemistry , Nuclear Proteins/immunology , Spindle Apparatus/metabolism , Tumor Cells, Cultured
11.
Crit Rev Eukaryot Gene Expr ; 9(3-4): 373-81, 1999.
Article in English | MEDLINE | ID: mdl-10651254

ABSTRACT

In higher eukaryotic cells the nuclear envelope is reversibly disassembled during mitosis. Under in vivo conditions this process occurs in a sequential, stepwise fashion and involves a variety of structural intermediates. Here we discuss the topological features of these intermediates and their transient interactions with chromatin and the cytoskeleton. As it becomes apparent, nuclear envelope disassembly and reassembly are regulated at multiple levels by modulating the affinity of protein-protein interactions, limiting the availability of structural subunits in different areas of the mitotic cytoplasm, and redirecting mechanical forces exerted by the microtubules.


Subject(s)
Cell Nucleus , Mitosis , Nuclear Envelope , Animals , Cell Nucleus/chemistry , Cell Nucleus/physiology , Cell Nucleus/ultrastructure , Humans , Nuclear Envelope/chemistry , Nuclear Envelope/physiology , Nuclear Envelope/ultrastructure
13.
Prenat Diagn ; 18(2): 133-7, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9516014

ABSTRACT

The aim of this screening study was to evaluate first-trimester screening for chromosomal defects by fetal nuchal translucency thickness at 10-14 weeks of gestation in four Fetal Medicine Units in Greece. Estimates of the risk for trisomy 21 were calculated taking into account fetal nuchal translucency thickness and maternal age. There were 3550 cases; the median maternal age was 29 years (range 16-48 years); and 277 (7.8 per cent) were over 37 years. The median crown rump length was 60 mm (range 38-85 mm) and the fetal nuchal translucency thickness increased with crown rump length and measurements were above the 95th centile in 101 (2.9 per cent) of the cases. The adjusted risk was 1 in 300 or more in 172 (4.9 per cent) of the cases and the high-risk group contained ten of the 11 (91 per cent) fetuses with trisomy 21 and all 11 fetuses with other chromosomal defects. The findings of this study provide further evidence for the high efficacy of screening for chromosomal abnormalities by fetal nuchal translucency and maternal age.


Subject(s)
Gestational Age , Maternal Age , Neck/diagnostic imaging , Ultrasonography, Prenatal , Adolescent , Adult , Chromosome Aberrations , Down Syndrome/diagnostic imaging , Female , Humans , Karyotyping , Middle Aged , Pregnancy , Risk Factors
14.
J Cell Sci ; 110 ( Pt 17): 2129-40, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9378763

ABSTRACT

We have studied nuclear envelope disassembly in mammalian cells by morphological methods. The first signs of nuclear lamina depolymerization become evident in early prophase as A-type lamins start dissociating from the nuclear lamina and diffuse into the nucleoplasm. While B-type lamins are still associated with the inner nuclear membrane, two symmetrical indentations develop on antidiametric sites of the nuclear envelope. These indentations accommodate the sister centrosomes and associated astral microtubules. At mid- to late prophase, elongating microtubules apparently push on the nuclear surface and eventually penetrate the nucleus. At this point the nuclear envelope becomes freely permeable to large ligands, as indicated by experiments with digitonin-treated cells and by the massive release of solubilized A-type lamins into the cytoplasm. At the prophase/prometaphase transition, the B-type lamina is fragmented, but 'islands' of lamin B polymer can still be discerned on the tips of congressing chromosomes. Finally, at metaphase, the lamin B polymer breaks down into small pieces, which tend to concentrate in the area of the mitotic spindle. Nuclear envelope breakdown is not prevented when the microtubules are depolymerized by nocodazole; however, the mode of nuclear lamina fragmentation in the absence of microtubules is markedly different from the normal one and involves multiple raffles and gaps, which develop rapidly along the entire surface of the nuclear envelope. These data suggest that nuclear envelope disassembly is a stepwise process in which the microtubules play an important part.


Subject(s)
Microtubules/physiology , Mitosis/physiology , Nuclear Envelope/metabolism , Adenocarcinoma , Animals , Biomarkers , Endometrial Neoplasms , Female , Humans , Kidney/cytology , Lamin Type B , Lamins , Metaphase/physiology , Microscopy, Electron , Microtubules/ultrastructure , Nuclear Envelope/chemistry , Nuclear Envelope/ultrastructure , Nuclear Proteins/analysis , Prophase/physiology , Rats , Tumor Cells, Cultured
15.
EMBO J ; 16(16): 4839-50, 1997 Aug 15.
Article in English | MEDLINE | ID: mdl-9305626

ABSTRACT

We have examined the in situ organization and nearest neighbours of the 'lamina-associated polypeptide-1' (LAP1), a type II membrane protein and a major constituent of the mammalian nuclear envelope. We show here that, during interphase, LAP1 forms multimeric assemblies which are suspended in the inner nuclear membrane and are specifically associated with B-type lamins. The LAP1-lamin B complex is distinct from analogous complexes formed by the 'lamina-associated polypeptide-2' (LAP2), another inner nuclear membrane protein, and includes a protein kinase. Upon nuclear envelope breakdown, LAP1 partitions with mitotic vesicles which carry nuclear lamin B. The LAP1 vesicles can be distinguished from fragments of the nuclear envelope containing LAP2 and exhibit a striking co-alignment with spindle microtubules. These observations suggest that the inner nuclear membrane comprises discrete territories which accommodate specific integral membrane proteins and are differentially disassembled during mitosis.


Subject(s)
DNA-Binding Proteins , Interphase , Membrane Proteins/metabolism , Mitosis , Nuclear Envelope/chemistry , Nuclear Proteins/metabolism , Spindle Apparatus/metabolism , Amino Acid Sequence , Animals , Antibodies, Monoclonal/immunology , Cell Line , Electrophoresis, Polyacrylamide Gel , Immunohistochemistry , Lamin Type B , Lamins , Membrane Proteins/immunology , Molecular Sequence Data , Nuclear Proteins/immunology , Peptide Fragments/chemistry , Phosphopeptides/metabolism , Protein Kinases/chemistry , Rats , Sequence Analysis , Spindle Apparatus/chemistry
16.
J Laryngol Otol ; 111(1): 75-6, 1997 Jan.
Article in English | MEDLINE | ID: mdl-9292140

ABSTRACT

Macroglossia is a potentially life-threatening problem. The multiple aetiologies responsible for this condition include cysts, tumours, amyloidosis, angioedema, and infections. Although injuries to the oral cavity are common, self-inflicted traumatic macroglossia is not common. We report a case of a comatose patient with limb contractures and severe trismus who developed entrapment of the tongue with progressive macroglossia and near auto-amputation of the tongue. The importance of early recognition and treatment of tongue entrapment in comatose patients is emphasised since this is a potentially reversible condition.


Subject(s)
Coma/complications , Macroglossia/etiology , Trismus/complications , Adult , Coma/pathology , Constriction, Pathologic , Fatal Outcome , Humans , Macroglossia/pathology , Male , Tongue/pathology , Trismus/pathology
17.
Biochem Pharmacol ; 52(9): 1339-46, 1996 Nov 08.
Article in English | MEDLINE | ID: mdl-8937443

ABSTRACT

Using the DNase I inhibition assay, fluorimetric measurements, and immunoblot analysis, we studied quantitatively changes in the actin polymerization dynamics in primary cultures of normal and malignant human lymphocytes, normal human endometrial cells, and in various leukemic and endometrial adenocarcinoma cell lines. The G/total-actin ratio of malignant cells was found to be 1.37 to 1.81-fold higher compared to normal cells, indicating that malignant cells express reduced amounts of polymerized actin. The above findings were corroborated by fluorescence measurements of the amounts of rhodamine-phalloidin-labeled F-actin in normal and neoplastic cells, which showed significantly lower F-actin content in malignant cell preparations. Moreover, the total actin content, as quantitated by the DNase I inhibition assay and by immunoblot analysis, was found to be significantly decreased in the primary cultures of malignant human lymphocytes and endometrial cells when compared to the total actin levels in corresponding normal cells. Proliferation and viability measurements of normal and neoplastic cells in culture, treated equally with cytochalasin B (CB), revealed an increased susceptibility of malignant cells to this anticytoskeletal agent. This was not due to increased CB incorporation in neoplastic cells, as indicated by 3H-CB uptake experiments. In addition, fluorescence microscopy, in the presence of graded concentrations of CB, showed destabilization of microfilaments in the poorly differentiated endometrial adenocarcinoma HEC-50 cells, compared to the well-differentiated Ishikawa cells. In conclusion, all investigated malignant cells are characterized by: (a) higher G/total-actin ratio; (b) decreased F- and total-actin content; and (c) lower resistance to CB treatment. These quantitatively determined parameters may represent potential biochemical indicators reflecting malignant transformation. Moreover, it seems worthwhile to explore whether or not the differential sensitivity of malignant cells to anticytoskeletal drugs may provide a valuable approach to the manipulation of malignant cells.


Subject(s)
Actins/metabolism , Cytochalasin B/pharmacology , Polymers/metabolism , Cell Division/drug effects , Cell Survival/drug effects , Cells, Cultured , Cytochalasin B/administration & dosage , Dose-Response Relationship, Drug , Endometrial Neoplasms/metabolism , Endometrium/metabolism , Female , Humans , Leukemia/metabolism , Lymphocytes/metabolism , Microscopy, Fluorescence , Tumor Cells, Cultured
18.
J Cell Biochem ; 62(2): 251-61, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8844405

ABSTRACT

Glucocorticoids, in addition to their well characterized effects on the genome, may affect cell function in a manner not involving genomic pathways. The mechanisms by which the latter is achieved are not yet clear. A possible means for this action may involve the actin cytoskeleton, since the dynamic equilibrium of actin polymerization changes rapidly following exposure to several stimuli, including hormones. The aim of the present work was to find out if glucocorticoids exert rapid, nongenomic effects on actin polymerization in Ishikawa human endometrial cells, which represent a well characterized in vitro cell model expressing functional glucocorticoid receptors. Short term exposure of the cells to the synthetic glucocorticoid dexamethasone resulted in an overall decrease of the G/total-actin ratio in a time- and dose-dependent manner. Specifically, in untreated Ishikawa cells the G/total-actin ratio was 0.48 +/- 0.01 (n = 26). It became 0.35 +/- 0.01 (n = 13, P < 0.01) following exposure to 10(-7) M dexamethasone for 15 min. This was induced by a significant decrease of the cellular G-actin level, without affecting the total actin content, indicating a rapid actin polymerization. This conclusion was fully confirmed by direct fluorimetry measurements, that showed a significant increase of the F-actin content by 44% (n = 6, P < 0.001) in cells treated with dexamethasone (10(-7)M, 15 min). The rapid dexamethasone-induced alterations of the state of actin polymerization were further supported by fluorescence microscopy. The latter studies showed that the microfilaments of cells pretreated with 10(-7)M dexamethasone for 15 min were more resistant to various concentrations of the antimicrofilament drug cytochalasin B, compared to untreated cells, implying microfilament stabilization. The action of dexamethasone on actin polymerization seems to be mediated via specific glucocorticoid binding sites, since the addition of the glucocorticoid antagonist RU486 completely abolished its effect. Moreover, it appears to act via non-transcriptional pathways, since actinomycin D did not block the dexamethasone-induced actin polymerization. In addition, cell treatment with 10(-7)M dexamethasone for 15 min fully reversed the forskolin-, but not the 8-bromo-cAMP-induced actin depolymerization. In line with these findings, the cAMP content of Ishikawa cells was decreased by 29.2% after a 15 min treatment with 10(-7)M dexamethasone (n = 4, P < 0.01). In conclusion, our results showed that dexamethasone induces rapid, time-, and dose-dependent changes in actin polymerization dynamics in Ishikawa cells. This action seems to be mediated via cAMP, involving probably nongenomic pathways. The above findings offer new perspectives for the understanding of the early cellular responses to glucocorticoids.


Subject(s)
Actins/analysis , Cyclic AMP/metabolism , Dexamethasone/pharmacology , Endometrium/drug effects , Glucocorticoids/pharmacology , Actin Cytoskeleton/drug effects , Binding Sites , Cell Line , Cytochalasin B/pharmacology , Dactinomycin/pharmacology , Endometrium/cytology , Female , Hormone Antagonists/pharmacology , Humans , Mifepristone/pharmacology , Nucleic Acid Synthesis Inhibitors/pharmacology , Polymers , RNA/biosynthesis
19.
J Clin Endocrinol Metab ; 80(1): 185-9, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7829610

ABSTRACT

CRH is produced by several intrauterine sites, including placenta and desidua, during pregnancy. However, no data are available regarding the presence of CRH in the nonpregnant uterus. We now report that CRH is produced in the epithelial cells of normally cycling human uterus and in an endometrial epithelial cell-derived tumor. Specifically, we have found that: 1) Northern blot hybridization analysis of normal glandular endometrium as well as of Ishikawa human endometrial adenocarcinoma cells showed the presence of the CRH messenger RNA; the size of the transcript seemed to be identical to that present in human placenta and rat hypothalamus; 2) immunoreactive CRH (ir-CRH) was detectable in normal dispersed glandular endometrial cells as well as in the Ishikawa adenocarcinoma cells; 3) gel filtration chromatography of normal glandular endometrial and Ishikawa cell extracts and their culture media showed that most ir-CRH present had the mol wt of the authentic CRH peptide; in addition, a larger form of ir-CRH was also present in both normal and tumoral endometrial epithelial cell extracts; the latter most probably correspondents to CRH precursor molecules; and 4) immunofluorescence staining of CRH in normal glandular endometrial and Ishikawa cells revealed a cytoplasm rich in granules positive for ir-CRH. Our findings suggest that CRH may play an important role in the physiological events taking place within the uterine cavity, since CRH seems to be present in nonpregnant as well as pregnant uteri. Since CRH is expressed in normal endometrial epithelial cells and in an epithelial tumoral cell line, we propose the use of the Ishikawa cell line as a convenient model for the in vitro study of endometrial CRH.


Subject(s)
Adenocarcinoma/metabolism , Corticotropin-Releasing Hormone/metabolism , Endometrial Neoplasms/metabolism , Endometrium/metabolism , Adenocarcinoma/pathology , Blotting, Northern , Chromatography, Gel , Endometrial Neoplasms/pathology , Endometrium/cytology , Epithelial Cells , Epithelium/metabolism , Female , Fluorescent Antibody Technique , Humans , Reference Values , Tumor Cells, Cultured
20.
Cell Biochem Funct ; 12(4): 267-74, 1994 Dec.
Article in English | MEDLINE | ID: mdl-7834816

ABSTRACT

The state of polymerization of actin and the organization of actin filaments is widely believed to be related to cellular transformation. Since the intracellular monomer (G) and filamentous (F) actin content reflects the state of microfilament polymerization, we measured the G/total actin ratio in primary cultures of normal and malignant human keratinocytes. In normal keratinocytes the mean value of this ratio was 0.30 +/- 0.03 (mean +/- SE, n = 15), while in basal cell carcinoma (BCC) keratinocytes it was 0.49 +/- 0.03 (n = 8) and in squamous cell carcinoma keratinocytes (SCC) 0.5 +/- 0.07 (n = 4), indicating a 1.7-fold increase of the G/total actin ratio in malignant cells. These results imply that the proportion of polymerized actin is decreased markedly in malignant keratinocytes, suggesting alterations of microfilament structures which probably occur during the transformation process. This was supported by the morphological changes of microfilament structures as assessed by fluorescence microscopy. A different distribution of actin filaments in normal and malignant cells became evident; stress-fibres were converging in patches at several points in SCC cells, when compared to normal keratinocytes. Furthermore, incubation of normal and malignant keratinocytes with cytochalasin B indicated differences in the resistance of their microfilament networks. After 1 h exposure to 10(-6) and 10(-5) M cytochalasin B, microfilaments in normal cells appeared to be less affected than their counterparts in neoplastic cells. Even in a high excess of cytochalasin B (10(-4) M), normal keratinocytes preserved their shape, while both basal cell and SCC were totally disrupted.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Actin Cytoskeleton/drug effects , Actins/analysis , Keratinocytes/metabolism , Carcinoma, Basal Cell/metabolism , Carcinoma, Squamous Cell/metabolism , Cells, Cultured , Cytochalasin B/pharmacology , Humans , Keratinocytes/drug effects , Keratinocytes/ultrastructure , Microscopy, Fluorescence , Skin/metabolism , Skin Neoplasms/metabolism , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...